GLASGOW AND CLYDE MEDICAL SERVICES LTD
No material changes in the last 30 days.
No snapshot from 90 days ago — start tracking from today.
No snapshot from 180 days ago — start tracking from today.
Opportunity 76/100 (strong), bankability 70/100. Strong seller-intent signal (60/100, director aged 65). Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (69/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 102| Metric | 2025-02-28 |
|---|---|
| Average employees | 200 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
Corporate timeline (5 events)Click to expand
- 2025-10-03📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-02-13🏢Company incorporatedAs GLASGOW AND CLYDE MEDICAL SERVICES LTD
- 2024-02-13➕MCLEAN, Jane Elizabeth appointeddirector
- 2024-02-13➕SYKES, Glen Campbell, Dr appointeddirector
- 2024-02-13📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Founder age: Director aged approximately 65 — succession pressure is live.
- +Young company: Only 2.4 years old — management layer unlikely to be developed.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primaryFounder aged 63+: Senior director is approximately 65. Approaching typical UK retirement age — succession thinking likely.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Glen Campbell Sykes Individual · British · DOB 12/1961 · age 65 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 13/02/2024 |
Mrs Jane Elizabeth Mclean Individual · British · DOB 11/1965 · age 61 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 13/02/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · PA postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ARGYLL AND BUTE CARE AND REPAIR→ SC221948 · est 2001 | — | — | — | 13 | 24y | 83 | 81y |
| CRISIS→ SC166079 · est 1996 · no financials extracted | — | — | — | — | 30y | 83 | 83y |
| INVERCLYDE ASSOCIATION FOR MENTAL HEALTH→ SC193571 · est 1999 · no financials extracted | — | — | — | — | 27y | 83 | 83y |
| MID ARGYLL YOUTH DEVELOPMENT SERVICES→ SC396832 · est 2011 · no financials extracted | — | — | — | — | 15y | 83 | 74y |
| THE HAVEN KILMACOLM→ SC252971 · est 2003 | — | — | £639.0k | — | 22y | 83 | 79y |
| ABBEY LABORATORY LIMITED→ SC227760 · est 2002 | — | — | £5.0k | — | 24y | 82 | 61y |
| ABDUL HALEEM LIMITED→ SC343438 · est 2008 | — | — | £1.68M | — | 18y | 82 | 59y |
| ARGYLL HOMECARE LIMITED→ SC275774 · est 2004 | — | — | — | 2300 | 21y | 82 | 59y |
| COMPLETE DENTISTRY LIMITED→ SC343834 · est 2008 | — | — | £244.7k | — | 18y | 82 | 59y |
| RAM 211 LIMITED→ SC384523 · est 2010 | — | — | — | 21 | 15y | 82 | 68y |
| WARDSIDE (HOLDINGS) LIMITED→ SC213967 · est 2000 | — | — | — | 0 | 25y | 82 | 76y |
| CATCH SCOTLAND LTD→ SC386586 · est 2010 | — | — | £345.6k | — | 15y | 81 | 82y |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.